A Case Series and Literature Review of Telogen Effluvium and Alopecia Universalis After the Administration of a Heterologous COVID-19 Vaccine Scheme

February 2023 in “ Vaccines ”

Jenny Hernández Arroyo, Juan S. Izquierdo-Condoy, Esteban Ortiz‐Prado

telogen effluvium alopecia universalis COVID-19 vaccine Pfizer/BioNTech vaccine hair loss Pfizer vaccine

TLDR Some people experienced hair loss after COVID-19 vaccination, but it's very rare and vaccines' benefits are greater than this risk.

The document discusses a case series of five individuals in Ecuador who developed hair loss conditions, specifically telogen effluvium and alopecia universalis, within 3 to 17 days after receiving a heterologous COVID-19 vaccination scheme. The study suggests a potential link between COVID-19 vaccines and hair loss, but the exact mechanism is unclear. The document also reviews 19 reported cases of alopecia associated with COVID-19 vaccines as of November 1, 2022, with the Pfizer/BioNTech vaccine being the most reported. The authors emphasize that these events are extremely rare and the benefits of COVID-19 vaccines outweigh the reported risk of hair loss. They recommend further studies with larger sample sizes to establish a causal relationship. Treatments for the hair loss showed varying degrees of improvement, with two patients showing 80% and 90% improvement respectively, while others showed less improvement.

View this study on mdpi.com →

Discuss this study in the Community →

Cited in this study

5 / 5 results

research Comorbidities in Alopecia Areata: A Systematic Review and Meta-Analysis

100 citations , February 2019 in “Journal of The American Academy of Dermatology”

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

research Alopecia Areata: Overview and Insights from January 2018

290 citations , January 2018 in “Journal of The American Academy of Dermatology”

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

research Hepatitis C Treatment and Alopecia Totalis

8 citations , December 2013 in “Journal of Investigative Dermatology Symposium Proceedings”

Hepatitis C treatment may trigger complete hair loss, especially in those with a history of patchy hair loss, but hair usually grows back within a year.

research Type 1 Interferon Signature in the Scalp Lesions of Alopecia Areata

52 citations , March 2010 in “British Journal of Dermatology”

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

research Hair Loss After Routine Immunizations

87 citations , October 1997 in “JAMA”

Some vaccines might rarely cause hair loss, more research is needed.

4 / 4 results

research Alopecia Areata: A Multifactorial Autoimmune Condition

148 citations , March 2019 in “Journal of autoimmunity”

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

research Treating Resistant Cases of Alopecia Universalis

May 2018 in “Journal of cosmetology & trichology”

Combining platelet-rich plasma therapy with prostaglandin-F eye drops can significantly regrow hair in alopecia universalis.

research Treatment of Alopecia Universalis with Oral Alitretinoin: A Case Report

2 citations , March 2017 in “JAAD case reports”

Oral alitretinoin can quickly regrow hair in alopecia universalis.

research Efficacy of Tofacitinib in Treatment of Alopecia Universalis in Two Patients

51 citations , June 2016 in “Journal of the European Academy of Dermatology and Venereology”

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.